(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally...
Stats | |
---|---|
Šios dienos apimtis | 642.00 |
Vidutinė apimtis | 8 930.00 |
Rinkos kapitalizacija | 14.80M |
EPS | $0 ( 2024-03-21 ) |
Kita pelno data | ( $0 ) 2024-05-07 |
Last Dividend | $0.0700 ( 2023-05-24 ) |
Next Dividend | $0 ( N/A ) |
P/E | -3.54 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-22 | Mehalik Daniella | Buy | 70 000 | Stock Option (Right to Buy) |
2024-01-22 | Mehalik Daniella | Buy | 35 000 | Stock Option (Right to Buy) |
2023-11-27 | Mehalik Daniella | Sell | 0 | Common Stock, $.005 Par Value |
2023-09-21 | Shoemaker Shannon | Buy | 80 000 | Stock Option (Right to Buy) |
2023-09-21 | Shoemaker Shannon | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
94.08 |
Last 96 transactions |
Buy: 1 000 549 | Sell: 33 710 |
Psychemedics Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
HALL | 0.894 |
GSM | 0.876 |
ALTA | 0.873 |
NEXI | 0.862 |
OSMT | 0.861 |
MRUS | 0.86 |
XPER | 0.855 |
SNCR | 0.848 |
PAYO | 0.847 |
SRZN | 0.844 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
CLDX | -0.902 |
BNIXU | -0.901 |
BLZE | -0.881 |
NUTX | -0.878 |
RDVT | -0.872 |
GLMD | -0.844 |
STIM | -0.843 |
BGNE | -0.843 |
COFS | -0.842 |
HALO | -0.842 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Psychemedics Corp Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $22.10M |
Bruto pelnas: | $8.41M (38.07 %) |
EPS: | $-0.720 |
FY | 2023 |
Pajamos: | $22.10M |
Bruto pelnas: | $8.41M (38.07 %) |
EPS: | $-0.720 |
FY | 2022 |
Pajamos: | $25.24M |
Bruto pelnas: | $9.29M (36.81 %) |
EPS: | $-0.190 |
FY | 2021 |
Pajamos: | $24.91M |
Bruto pelnas: | $10.26M (41.21 %) |
EPS: | $-0.119 |
Financial Reports:
No articles found.
Psychemedics Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0800 | 1997-01-13 |
Last Dividend | $0.0700 | 2023-05-24 |
Next Dividend | $0 | N/A |
Payout Date | 2023-06-08 | |
Next Payout Date | N/A | |
# dividends | 100 | -- |
Total Paid Out | $12.60 | -- |
Avg. Dividend % Per Year | 1.61% | -- |
Score | 2.88 | -- |
Div. Sustainability Score | 2.34 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0.792 | -- |
Year | Amount | Yield |
---|---|---|
1997 | $0.400 | 1.67% |
1998 | $0.440 | 1.87% |
1999 | $0.640 | 3.20% |
2000 | $0.640 | 3.56% |
2001 | $0.400 | 2.00% |
2002 | $0.240 | 1.46% |
2003 | $0.320 | 3.43% |
2004 | $0.320 | 3.37% |
2005 | $0.360 | 2.82% |
2006 | $0.475 | 3.39% |
2007 | $0.575 | 2.99% |
2008 | $0.660 | 4.13% |
2009 | $0.580 | 9.01% |
2010 | $0.480 | 6.08% |
2011 | $0.480 | 5.66% |
2012 | $0.600 | 6.49% |
2013 | $0.600 | 5.52% |
2014 | $0.600 | 4.14% |
2015 | $0.600 | 3.98% |
2016 | $0.600 | 6.17% |
2017 | $0.600 | 2.50% |
2018 | $0.690 | 3.33% |
2019 | $0.720 | 4.46% |
2020 | $0.180 | 2.00% |
2021 | $0.0500 | 0.97% |
2022 | $0.210 | 2.94% |
2023 | $0.140 | 2.84% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.188 | 1.500 | -3.76 | -5.64 | [0 - 0.5] |
returnOnAssetsTTM | -0.313 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | -0.498 | 1.500 | -6.64 | -9.96 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.445 | 0.800 | 7.77 | 6.22 | [1 - 3] |
quickRatioTTM | 1.204 | 0.800 | 7.62 | 6.10 | [0.8 - 2.5] |
cashRatioTTM | 0.417 | 1.500 | 8.79 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.173 | -1.500 | 7.11 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 4.22 | 1.000 | 9.55 | 9.55 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.255 | 2.00 | -0.0850 | -0.170 | [0 - 30] |
freeCashFlowPerShareTTM | -0.277 | 2.00 | -0.138 | -0.277 | [0 - 20] |
debtEquityRatioTTM | 0.344 | -1.500 | 8.62 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.381 | 1.000 | 6.99 | 6.99 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.132 | 1.000 | -4.64 | -4.64 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.644 | 1.000 | -4.69 | -4.69 | [0.2 - 2] |
assetTurnoverTTM | 1.665 | 0.800 | 2.23 | 1.785 | [0.5 - 2] |
Total Score | 2.34 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -3.56 | 1.000 | -0.461 | 0 | [1 - 100] |
returnOnEquityTTM | -0.498 | 2.50 | -4.27 | -9.96 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.277 | 2.00 | -0.0923 | -0.277 | [0 - 30] |
dividendYielPercentageTTM | 2.75 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.255 | 2.00 | -0.0850 | -0.170 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.239 | 1.500 | -1.741 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.0670 | 1.000 | -4.17 | 0 | [0.1 - 0.5] |
Total Score | -0.760 |
Psychemedics Corp
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.